Literature DB >> 11082286

Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia.

J N Li1, M A Mahmoud, W F Han, M Ripple, E S Pizer.   

Abstract

Endogenous fatty acid synthesis has been observed in certain rapidly proliferating normal and neoplastic tissues. Sterol regulatory element-binding proteins (SREBPs) are transcription factors that regulate the expression of lipogenic genes including fatty acid synthase (FAS), the major biosynthetic enzyme for fatty acid synthesis. We have previously shown that SREBP-1, FAS, and Ki-67, a proliferation marker, colocalized in the crypts of the fetal gastrointestinal tract epithelium. This study sought to determine whether SREBP-1 participates in the regulation of proliferation-associated fatty acid synthesis in colorectal neoplasia. An immunohistochemical analysis of SREBP-1, FAS, and Ki-67 expression in 25 primary human colorectal carcinoma specimens showed colocalization in 22 of these. To elucidate a functional linkage between SREBP-1 activation and proliferation-associated FA synthesis, SREBP-1 and FAS content were assayed during the adaptive response of cultured HCT116 colon carcinoma cells to pharmacological inhibition of FA synthesis. Cerulenin and TOFA each inhibited the endogenous synthesis of fatty acids in a dose-dependent manner and each induced increases in both precursor and mature forms of SREBP-1. Subsequently, both the transcriptional activity of the FAS promoter in a luciferase reporter gene construct and the FAS expression increased. These results demonstrate that tumor cells recognize and respond to a deficiency in endogenous fatty acid synthesis by upregulating both SREBP-1 and FAS expression and support the model that SREBP-1 participates in the transcriptional regulation of lipogenic genes in colorectal neoplasia. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082286     DOI: 10.1006/excr.2000.5054

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  24 in total

1.  The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells.

Authors:  Hiu-Yee Kwan; Zhijun Yang; Wang-Fun Fong; Yong-Mei Hu; Zhi-Ling Yu; Wen-Luan Wendy Hsiao
Journal:  J Gastroenterol       Date:  2012-06-23       Impact factor: 7.527

2.  Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation.

Authors:  A Young Kim; Yun Sok Lee; Kang Ho Kim; Jae Ho Lee; Hee Kyu Lee; Su-Hwa Jang; Seong-Eun Kim; Gha Young Lee; Joo-Won Lee; Sung-Ae Jung; Hee Yong Chung; Sunjoo Jeong; Jae Bum Kim
Journal:  Mol Endocrinol       Date:  2010-05-05

3.  Betulinic acid induces a novel cell death pathway that depends on cardiolipin modification.

Authors:  L Potze; S Di Franco; C Grandela; M L Pras-Raves; D I Picavet; H A van Veen; H van Lenthe; F B Mullauer; N N van der Wel; A Luyf; A H C van Kampen; S Kemp; V Everts; J H Kessler; F M Vaz; J P Medema
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

4.  p54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A.

Authors:  Z Zhu; X Zhao; L Zhao; H Yang; L Liu; J Li; J Wu; F Yang; G Huang; J Liu
Journal:  Oncogene       Date:  2015-07-06       Impact factor: 9.867

5.  SREBP1 promotes 5-FU resistance in colorectal cancer cells by inhibiting the expression of caspase7.

Authors:  Yuyan Gao; Qi Zhao; Xiaoqin Mu; Huifen Zhu; Binbin Liu; Bingqing Yao; Xinyi Liu; Wenhan Xue; Bo Wang; Shulin Liu
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

6.  The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy.

Authors:  Ying-En Lee; Hong-Lin He; Yow-Ling Shiue; Sung-Wei Lee; Li-Ching Lin; Ting-Feng Wu; I-Wei Chang; Hao-Hsien Lee; Chien-Feng Li
Journal:  Tumour Biol       Date:  2015-05-01

7.  Metabolomics in bladder cancer: a systematic review.

Authors:  Yidong Cheng; Xiao Yang; Xiaheng Deng; Xiaolei Zhang; Pengchao Li; Jun Tao; Chao Qin; Jifu Wei; Qiang Lu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

8.  Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker.

Authors:  Hailan Liu; Jing-Yuan Liu; Xi Wu; Jian-Ting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2010-07-18

9.  Liver fatty acid-binding protein (L-Fabp) modifies intestinal fatty acid composition and adenoma formation in ApcMin/+ mice.

Authors:  Sekhar Dharmarajan; Elizabeth P Newberry; Grace Montenegro; Ilke Nalbantoglu; Victoria R Davis; Michael J Clanahan; Valerie Blanc; Yan Xie; Jianyang Luo; James W Fleshman; Susan Kennedy; Nicholas O Davidson
Journal:  Cancer Prev Res (Phila)       Date:  2013-08-06

10.  Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma.

Authors:  Samiksha Bansal; Michael Berk; Naim Alkhouri; David A Partrick; John J Fung; Ariel Feldstein
Journal:  J Surg Res       Date:  2013-07-27       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.